1346576-38-2

Usage

Uses

Used in Pharmaceutical Industry:
1H-Indole-4-carboxylic acid, 6-bromo-3-formyl-1-(1-methylpropyl)-, methyl ester is used as a starting material or intermediate for the synthesis of pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications, contributing to the advancement of medicine.
Used in Agrochemical Industry:
In the agrochemical industry, 1H-Indole-4-carboxylic acid, 6-bromo-3-formyl-1-(1-methylpropyl)-, methyl ester is utilized as a building block for the creation of agrochemicals. Its potential role in the synthesis of molecules with pesticidal or herbicidal properties makes it a valuable component in the development of effective and environmentally friendly agricultural solutions.
Used in Organic Compounds Synthesis:
1H-Indole-4-carboxylic acid, 6-bromo-3-formyl-1-(1-methylpropyl)-, methyl ester is used as a versatile intermediate in the synthesis of various organic compounds. Its unique structure and reactivity enable the production of a wide range of molecules with specific properties, applicable across different industries, including materials science, fragrances, and dyes.

Upstream product

• 107650-22-6 methyl 6-bromo-1-isopropyl-3-methyl-1H-indole-4-carboxylate 
• 220514-28-3 5-bromo-2-methyl-3-nitrobenzoic acid methyl ester 
• 1975-50-4 2-methyl-3-nitrobenzic acid 
• 107650-20-4 5-bromo-2-methyl-3-nitro-benzoic acid 

Downstream Products

• 1346576-39-3 methyl 6-bromo-1-(sec-butyl)-3-methyl-1H-indole-4-carboxylate 
• 1346574-61-5 6-{3-[(dimethylamino)methyl]phenyl}-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1R)-1-methylpropyl]-1H-indole-4-carboxamide 
• 1346574-60-4 6-{3-[(dimethylamino)methyl]phenyl}-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-1H-indole-4-carboxamide 
• 1346574-57-9 GSK-126 
• 1346574-55-7 (R)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide 
• 1346574-54-6 (S)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide 
• 1346574-59-1 6-{3-[(dimethylamino)methyl]phenyl}-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylpropyl)-1H-indole-4-carboxamide 
• 1346574-53-5 6-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylpropyl)-1H-indole-4-carboxamide 
• 1346575-54-9 6-bromo-1-(sec-butyl)-3-methyl-1H-indole-4-carboxylic acid 

Relevant academic research and scientific papers

SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

The present invention relates to substituted benzene compounds and bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS

The present invention relates to 1,4-pyridone bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical co

METHOD OF TREATMENT

The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.